# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-22-000728
Filing Date
2022-04-11
Accepted
2022-04-11 06:03:27
Documents
90
Period of Report
2022-02-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | lxrp_10q.htm iXBRL | 10-Q | 997690
2 | EX-31.1 | lxrp_ex311.htm | EX-31.1 | 12245
3 | EX-31.2 | lxrp_ex312.htm | EX-31.2 | 12312
4 | EX-32.1 | lxrp_ex321.htm | EX-32.1 | 4886
5 | EX-32.2 | lxrp_ex322.htm | EX-32.2 | 6063
11 |  | lxrp_10qimg510.jpg | GRAPHIC | 1582
| Complete submission text file | 0001640334-22-000728.txt |  | 5184186

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | lxrp-20220228.xsd | EX-101.SCH | 57610
7 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | lxrp-20220228_lab.xml | EX-101.LAB | 289944
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | lxrp-20220228_cal.xml | EX-101.CAL | 50736
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | lxrp-20220228_pre.xml | EX-101.PRE | 244560
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | lxrp-20220228_def.xml | EX-101.DEF | 110241
84 | EXTRACTED XBRL INSTANCE DOCUMENT | lxrp_10q_htm.xml | XML | 972498

Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-39874 | Film No.: 22818407
SIC: 2834 Pharmaceutical Preparations